Final results from GCIG/ENGOT/AGO-OVAR 12, a randomised placebo-controlled phase III trial of nintedanib combined with chemotherapy for newly diagnosed advanced ovarian cancer

1. Ray-Coquard, I.
2. Cibula, D.
3. Mirza, M.R.
4. Reuss, A.
5. Ricci, C.
6. Colombo, N.
7. Koch, H.
8. Goffin, F.
9. González-Martin, A.
10. Ottevanger, P.B.
11. Baumann, K.
12. Bjørge, L.
13. Lesoin, A.
14. Burges, A.
15. Rosenberg, P.
16. Gropp-Meier, M.
17. Harrela, M.
18. Harter, P.
19. Frenel, J.-S.
20. Minarik, T.
21. Pisano, C.
22. Hasenburg, A.
23. Merger, M.
24. du Bois, A.